Overview A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder. Status: Recruiting Trial end date: 2024-05-21 Target enrollment: Participant gender: Summary The primary purpose of this trial is to evaluate the safety and tolerability of centanafadine QD XR in pediatric subjects with ADHD. Phase: Phase 3 Details Lead Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.